BrainVectis gains approval for Phase I/II Huntington’s gene therapy trial
24 Aug 2022 //
CLINICALTRIALSARENA
BrainVectis receives clearance to conduct PI/II trial for its novel gene therapy
23 Aug 2022 //
PRNEWSWIRE
24 Aug 2022 //
CLINICALTRIALSARENA
23 Aug 2022 //
PRNEWSWIRE
Market Place
Sourcing Support